The Honorable Jim Greenwood discusses the art and science of multi-stakeholder collaborations The Honorable Jim Greenwood, President and CEO of Biotechnology Industry Organization (BIO) and C-Path Board member, participated
PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force
Identifying and Measuring the Core Symptoms Reported by Persons with Asthma: A review of the Existing Qualitative Literature and Patient-Reported Outcome Measures
An Expanded Role for Patients in Clinical Trial Design – Podcast A discussion with Dr. Anne Rowzee of the Center for Drug Evaluation and Research, US FDA about patient input into the design of st
September 10, 2013 Implementing New Clinical Outcome Assessment Instruments on Alternative Data Collection Modes: The Electronic Implementation Assessment and Migration Process
